Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Protease",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release AnaSpec introduces 25 new catalogue peptides from
AnaSpec, which we summarised at the time by saying "This week AnaSpec, one of the world's largest providers of custom and catalogue peptides, introduced twenty-five (25) new catalogue peptides".
Earlier in the week,
we featured the news release Wako is sales and marketing partner for Japan from
Fluorotechnics: "Fluorotechnics announces the immediate appointment of Wako Pure Chemical Industries, as a sales, marketing and distribution partner for Japan".
In January 2008, we covered the news from Waters
concerning its Synapt MS
- take a look at Expanding the boundaries of mass spectrometry
which says: "Waters has launched its Synapt MS system, describing it as a next-generation quadrupole orthogonal acceleration, time-of-flight (oa-Tof) mass spectrometry (MS) platform".
Take a look also at the news release from AnaSpec, AnaSpec's new brochure covers Fret technology,
as well as First-ever biorisk-free growth factors from ORF Genetics,
and Outsourcing of assay development speeds discovery from Nanostream.
See also:
First protease assay kits for West Nile Virus
(May 2007)
With the SensoLyte series of WNV protease assay kits, AnaSpec has introduced the industry's first commercially available assay kits for the detection of West Nile Virus (WNV) protease NS3 inhibitors
Just which one is your favourite gene?
(May 2007)
Sigma-Aldrich introduces Your Favorite Gene, a new comprehensive, web-based search tool that matches genes of interest against thousands of Sigma-Aldrich research products
Ultimate purification of the Rab11-FIP2 complex
(April 2007)
Since Rab11 in solution is a monomer, the light scattering data suggest that FIP2 forms homodimers and recruits two molecules of Rab11 during trafficking of Rab11-positive endosomes
Simultaneously measure live and dead cells
(October 2006)
The MultiTox-Fluor multiplex cytotoxicity assay is a novel technology for measuring the relative number of live and dead cells in culture
Distribution for peptide-based enzyme profiling
(September 2006)
Millipore and JPT Peptide Technologies (JPT), a wholly-owned subsidiary of Berlin-based Jerini, have announced a distribution and marketing agreement
Novel peptides and proteins for therapeutic use
(August 2006)
Activotec has an extensive ongoing R+D programme targeted at developing novel methods for the modification and production of peptides and proteins for therapeutic use
HCV proteases - wild-type and mutated
(July 2006)
The Hepatitis C Virus (HCV) NS3/4A serine protease, essential for HCV replication and the formation of infectious viral particles, is considered one of the most attractive targets for anti-HCV therapy
Ultra-sensitive HCV NS3/4A protease Fret substrate
(July 2006)
Applying both peptide and fluorescent dye technologies, AnaSpec has developed an ultra-sensitive HCV NS3/4A protease Fret substrate that can detect presence of HCV NS3/4A protease at <0.1pmol
The only HTS assay kits for screening HCV NS3/4A
(July 2006)
EnzoLyte assay kits are specifically designed for the detection and quantification of NS3/4A protease activity at subnanomolar concentrations and can be used in 96- or 384-well microplate format
Plasma glycoprotein promotes cellular adhesion
(March 2006)
Vitronectin is an extracellular soluble disulfide linked dimer composed of a 75 kDa and a 65 kDa peptide chain with a molecular weight of 140 kDa
Measure cell death only in target populations
(November 2005)
Assay kit allows researchers to look specifically at Granzyme B activity in target cells by flow cytometry or microscopy and measure cell death exclusively in target cell populations
Medicinal chemistry services director appointed
(August 2005)
Peakdale announces the appointment of 'industry figurehead' Terry Hart in order to drive further medicinal chemistry capabilities and enhance its range of services
Double-digit growth for antivirals
(June 2005)
Growth rates recently enjoyed by the world market for prescription antiviral medications will peak in the 2005-2006 period at nearly 17% before falling to more modest levels by the end of the decade
Rapid, sensitive and flexible assay for DPPIV
(April 2005)
DPPIV is a multifunctional protein involved in cleaving incretin hormones, hence serving to regulate glucose homeostasis and consequently viewed as a target for the management of Type 2 diabetes
World's largest parallel protein production site
(March 2005)
Monash University, in the Australian state of Victoria, becomes home to 12-module protein production system which, in combination with forthcoming synchrotron, will significantly boost science
Conference covers medical chemistry
(December 2004)
MedChem Europe, Berlin, 13-14 April 2005, will include topics of interest in the pharmaceutical industry and encompasses major target families such as kinases, GPCRs, and proteases
Software predicts potential malaria therapeutics
(September 2004)
IDBS and Medical Research Council Technology collaboration validates efficacy of PredictionBase, heralding new era of model-based drug discovery
Speed and versatility in microplate detection
(February 2004)
Fully modular monochromator-based microplate detection system offers a range of high-speed fluorescence techniques
Microplate reader promises a new level of speed
(February 2004)
Fully modular monochromator-based microplate detection system offers a range of high-speed fluorescence techniques
Developing effective and inexpensive anti-venom
(January 2004)
Automated image analyser is allowing scientists at the Liverpool School of Tropical Medicine to rapidly check the quality of DNA being used to generate life saving anti-venom
In vitro translation provides apoptosis insight
(November 2003)
A lot of the interest in apoptosis mediation has focused on serine proteases, but research is at a very early stage so little is known about how these enzymes affect apoptosis
Development of novel Factor Xa inhibitors
(October 2003)
Curacyte awarded a grant from the German state of Thuringia to fund lead optimisation and pre-clinical development of novel orally available Factor Xa inhibitors
New anti-tumour agents discovered
(June 2003)
A series of novel small molecule inhibitors of matriptase, a trypsin-like serine protease, might provide a route to prevent tumour metastasis and invasive growth
High performance tips for pipettes
(June 2003)
Pipette tip geometry can influence both accuracy and precision, allowing a droplet so small it can hardly be seen to have major implications in many laboratories
Activated protein C for coagulation research
(March 2003)
Anticoagulant serine protease that can be used to study coagulation in relation to particular proteins, such as factor VIII
Analysis of HIV/Aids therapies
(February 2003)
New analysis reveals that US revenues in this industry totalled $3.03 billion in 2002, and are projected to reach $10.88 billion by 2009
'Gold standard' for MS grade trypsin
(January 2003)
Especially produced for mass spectrometry (MS) proteomic research, peptide fragments generated by Trypsin Gold are suitable for reliable and accurate mass spectrometric database analysis
Compounds assist malaria drug development
(December 2002)
MRC researchers achieve a significant hit-rate when using screening compounds in a novel high throughput screening (HTS) assay designed to identify potential anti-malaria agents